365 related articles for article (PubMed ID: 34427584)
61. Sensitivity to targeted UBA1 inhibition in a myeloid cell line model of VEXAS syndrome.
Chiaramida A; Obwar SG; Nordstrom AEH; Ericsson M; Saldanha A; Ivanova EV; Griffin GK; Khan DH; Belizaire R
Blood Adv; 2023 Dec; 7(24):7445-7456. PubMed ID: 38091008
[TBL] [Abstract][Full Text] [Related]
62. Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases.
Jachiet V; Ricard L; Hirsch P; Malard F; Pascal L; Beyne-Rauzy O; Peterlin P; Maria ATJ; Vey N; D'Aveni M; Gourin MP; Dimicoli-Salazar S; Banos A; Wickenhauser S; Terriou L; De Renzis B; Durot E; Natarajan-Ame S; Vekhoff A; Voillat L; Park S; Vinit J; Dieval C; Dellal A; Grobost V; Willems L; Rossignol J; Solary E; Kosmider O; Dulphy N; Zhao LP; Adès L; Fenaux P; Fain O; Mohty M; Gaugler B; Mekinian A;
Clin Exp Med; 2023 Jul; 23(3):803-813. PubMed ID: 35953763
[TBL] [Abstract][Full Text] [Related]
63. Case report of a patient with VEXAS syndrome.
Tsourveloudis I; Georgiadi EC; Vatalis G; Kotsi P
Medicine (Baltimore); 2023 Dec; 102(52):e36738. PubMed ID: 38206689
[TBL] [Abstract][Full Text] [Related]
64. USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly Patients.
Delplanque M; Aouba A; Hirsch P; Fenaux P; Graveleau J; Malard F; Roos-Weil D; Belfeki N; Drevon L; Oganesyan A; Groh M; Mahévas M; Razanamahery J; Maigne G; Décamp M; Miranda S; Quemeneur T; Rossignol J; Sailler L; Sébert M; Terriou L; Sevoyan A; Hakobyan Y; Georgin-Lavialle S; Mekinian A
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884286
[TBL] [Abstract][Full Text] [Related]
65. A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment.
Tozaki N; Tawada C; Niwa H; Mizutani Y; Shu E; Kawase A; Miwa Y; Ohnishi H; Sasai H; Miyako K; Hosokawa J; Kato A; Kobayashi K; Miyazaki T; Shirakami Y; Shimizu M; Iwata H
Front Med (Lausanne); 2022; 9():1046820. PubMed ID: 36544501
[TBL] [Abstract][Full Text] [Related]
66. Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies.
Sakuma M; Blombery P; Meggendorfer M; Haferlach C; Lindauer M; Martens UM; Kern W; Haferlach T; Walter W
Leukemia; 2023 May; 37(5):1080-1091. PubMed ID: 36823397
[TBL] [Abstract][Full Text] [Related]
67. Vasculitis associated with VEXAS syndrome: A literature review.
Watanabe R; Kiji M; Hashimoto M
Front Med (Lausanne); 2022; 9():983939. PubMed ID: 36045928
[TBL] [Abstract][Full Text] [Related]
68. VEXAS within the spectrum of rheumatologic disease.
Koster MJ; Warrington KJ
Semin Hematol; 2021 Oct; 58(4):218-225. PubMed ID: 34802543
[TBL] [Abstract][Full Text] [Related]
69. VEXAS syndrome in dermatology.
Afsahi V; Christensen RE; Alam M
Arch Dermatol Res; 2023 Mar; 315(2):161-164. PubMed ID: 35201420
[TBL] [Abstract][Full Text] [Related]
70. Somatic mutations in VEXAS Syndrome and Erdheim-Chester disease: Inflammatory myeloid diseases.
Alcedo PE; Gutierrez-Rodrigues F; Patel BA
Semin Hematol; 2022 Jul; 59(3):156-166. PubMed ID: 36115693
[TBL] [Abstract][Full Text] [Related]
71. Ocular and orbital manifestations in VEXAS syndrome.
Abumanhal M; Leibovitch I; Zisapel M; Eviatar T; Edel Y; Ben Cnaan R
Eye (Lond); 2024 Jun; 38(9):1748-1754. PubMed ID: 38548942
[TBL] [Abstract][Full Text] [Related]
72. UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome.
Zakine E; Schell B; Battistella M; Vignon-Pennamen MD; Chasset F; Mahévas T; Cordoliani F; Adès L; Sébert M; Delaleu J; Jachiet M; Lepelletier C; Lemaire P; Chauvel C; Dhouaieb B; Kim R; Cassius C; Georgin-Lavialle S; Mekinian A; Bagot M; Braun T; Rousset L; Begon E; de Masson A; Fenaux P; Clappier E; Bouaziz JD
JAMA Dermatol; 2021 Nov; 157(11):1349-1354. PubMed ID: 34495287
[TBL] [Abstract][Full Text] [Related]
73. Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome.
Lecoeuvre H; Le Gall F; Le Naoures C; Vignon-Pennamen MD; Lamaison C; Kammerer-Jacquet SF; Lescoat A; Oger E; Pastoret C; Dupuy A
Clin Exp Dermatol; 2024 Feb; ():. PubMed ID: 38366665
[TBL] [Abstract][Full Text] [Related]
74. VEXAS syndrome: a diagnostic puzzle.
Ruffer N; Krusche M
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37532466
[TBL] [Abstract][Full Text] [Related]
75. A Case of VEXAS: Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic Syndrome With Co-existing DNA (Cytosine-5)-Methyltransferase 3A Mutation Complicated by Localized Skin Reaction to Tocilizumab and Azacitidine.
Estes J; Malus M; Wilson L; Grayson PC; Maz M
Cureus; 2023 Jun; 15(6):e39906. PubMed ID: 37404435
[TBL] [Abstract][Full Text] [Related]
76. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
Borie R; Debray MP; Guedon AF; Mekinian A; Terriou L; Lacombe V; Lazaro E; Meyer A; Mathian A; Ardois S; Vial G; Moulinet T; Terrier B; Jamilloux Y; Heiblig M; Bouaziz JD; Zakine E; Outh R; Groslerons S; Bigot A; Flamarion E; Kostine M; Henneton P; Humbert S; Constantin A; Samson M; Bertrand NM; Biscay P; Dieval C; Lobbes H; Jeannel J; Servettaz A; Adelaide L; Graveleau J; de Sainte-Marie B; Galland J; Guillotin V; Duroyon E; Templé M; Bourguiba R; Georgin Lavialle S; Kosmider O; Audemard-Verger A;
Chest; 2023 Mar; 163(3):575-585. PubMed ID: 36272567
[TBL] [Abstract][Full Text] [Related]
77. Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome.
Ospina Cardona D; Rodriguez-Pinto I; Iosim S; Bonet N; Mensa-Vilaro A; Wong MK; Ho G; Tormo M; Yagüe J; Shon W; Wallace D; Casals F; Beck DB; Abuav R; Arostegui JI
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38552317
[TBL] [Abstract][Full Text] [Related]
78. Shared and Distinct Mechanisms of UBA1 Inactivation Across Different Diseases.
Collins JC; Magaziner SJ; English M; Hassan B; Chen X; Balanda N; Anderson M; Lam A; Fernandez-Pol S; Kwong B; Greenberg PL; Terrier B; Likhite ME; Kosmider O; Wang Y; Samara NL; Walters KJ; Beck DB; Werner A
bioRxiv; 2023 Oct; ():. PubMed ID: 37873213
[TBL] [Abstract][Full Text] [Related]
79. VEXAS syndrome: A dermatological perspective.
Nguyen JK; Routledge D; van Der Weyden C; Blombery P; Angel CM; Johnson D; Goh MS; Lee A
Australas J Dermatol; 2022 Nov; 63(4):488-492. PubMed ID: 36197697
[TBL] [Abstract][Full Text] [Related]
80. VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis.
Muratore F; Marvisi C; Castrignanò P; Nicoli D; Farnetti E; Bonanno O; Longo R; Zaldini P; Galli E; Balanda N; Beck DB; Grayson PC; Pipitone N; Boiardi L; Salvarani C
Arthritis Rheumatol; 2022 Apr; 74(4):665-670. PubMed ID: 34611997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
